Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
0.00
+0.0196 (0.46%)
May 7, 2026, 11:16 AM EDT - Market open
Molecular Partners AG Employees
Molecular Partners AG had 134 employees as of December 31, 2025. The number of employees decreased by 25 or -15.46% compared to the previous year.
Employees
134
Change
-25
Growth
-15.46%
Revenue / Employee
n/a
Profits / Employee
-$580,216
Market Cap
157.48M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 134 | -25 | -15.46% |
| Jun 30, 2025 | 153 | -9 | -5.50% |
| Dec 31, 2024 | 159 | -9 | -5.37% |
| Jun 30, 2024 | 162 | -7 | -3.92% |
| Dec 31, 2023 | 168 | -8 | -4.45% |
| Jun 30, 2023 | 169 | 5 | 2.74% |
| Dec 31, 2022 | 175 | 12 | 7.41% |
| Jun 30, 2022 | 164 | 12 | 7.89% |
| Dec 31, 2021 | 163 | 18 | 12.24% |
| Mar 31, 2021 | 152 | 17 | 12.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Alps Group | 93 |
| Agenus | 81 |
| InflaRx | 65 |
| Spero Therapeutics | 25 |
| TuHURA Biosciences | 22 |
| Black Diamond Therapeutics | 21 |
| Edesa Biotech | 17 |
| Galectin Therapeutics | 9 |
MOLN News
- 3 days ago - Molecular Partners to hold oral presentations on DLL3-targeting Radio-DARPin candidate MP0712 at multiple upcoming scientific conferences - GlobeNewsWire
- 6 days ago - Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling - GlobeNewsWire
- 17 days ago - Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712 - GlobeNewsWire
- 22 days ago - Molecular Partners Announces all Board Proposals Approved, Clare Fisher Elected as New Board Member at Annual General Meeting - GlobeNewsWire
- 6 weeks ago - Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors - GlobeNewsWire
- 7 weeks ago - Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins' Amenability to Multiple Isotopes - GlobeNewsWire
- 7 weeks ago - Molecular Partners to Hold Three Poster Presentations at AACR 2026 - GlobeNewsWire
- 7 weeks ago - Molecular Partners Reports Highlights and Financial Results for Full Year 2025 - GlobeNewsWire